Skip to main content
SpringerLink
Log in

Revision of quality control limits for broth microdilution tests of fleroxacin and gentamicin withPseudomonas aeruginosa ATCC 27853

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fuchs PC, Jones RN, Barry AL, Ayers LW, Gaven TL, Gerlach EH, Thornsberry C RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria. Diagnostic Microbiology and Infectious Disease 1987, 7: 29–35.

    PubMed  Google Scholar 

  2. Barry AL, Reller LB, Miller GH, Washington JA, Schoenknecht FD, Peterson LR, Hare RS, Knapp C Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility ofPseudomonas aeruginosa to aminoglycosides. Journal of Clinical Microbiology 1992, 30: 585–589.

    PubMed  Google Scholar 

  3. Hohl P, Felber AM Effect of method, media, pH and inoculum on the in vitro antibacterial activities of fleroxacin and norfloxacin. Journal of Antimicrobial Chemotherapy 1988, 22, Supplement D: 71–80.

    PubMed  Google Scholar 

  4. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing. Fourth informational supplement M100-S4. NCCLS, Villanova, PA, 1992.

    Google Scholar 

  5. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3, NCCLS, Villanova, PA, 1993.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Clinical Microbiology Institute, PO Box 947, 97062, Tualatin, Oregon, USA

    A. L. Barry

  2. Indiana University Medical Center, 46202, Indianapolis, Indiana, USA

    S. D. Allen

  3. St. Francis Hospital and Medical Center, 97225, Portland, Oregon, USA

    P. C. Fuchs

  4. University of Texas Health Sciences Center, 78284-7750, San Antonio, Texas, USA

    J. H. Jorgensen

  5. Oregon Health Sciences University, 97201, Portland, Oregon, USA

    M. A. Pfaller

Authors
  1. A. L. Barry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. D. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. C. Fuchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. H. Jorgensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. A. Pfaller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barry, A.L., Allen, S.D., Fuchs, P.C. et al. Revision of quality control limits for broth microdilution tests of fleroxacin and gentamicin withPseudomonas aeruginosa ATCC 27853. Eur. J. Clin. Microbiol. Infect. Dis. 13, 1087–1089 (1994). https://doi.org/10.1007/BF02111838

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111838

Keywords

Search

Navigation